CASI Pharmaceuticals Ratios (2020-2025) | CASIF

Ratios Dec2020 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter) 58.77%58.75%58.42%107.10%59.53%59.41%58.72%59.05%52.98%51.95%51.91%24.17%58.00%49.29%22.96%51.14%
EBT Margin (Quarter) -77.09%-74.75%-54.99%-146.50%-86.41%-95.16%-51.97%234.46%-282.96%-230.49%-116.13%-103.21%-169.49%-277.03%-326.54%-1,068.86%
EBIT Margin (Quarter) -77.09%-74.75%-55.98%-145.89%-86.41%-95.16%-57.65%234.68%-277.32%-220.88%-108.61%-96.69%-166.33%-266.47%-347.22%-1,068.86%
EBITDA Margin (Quarter) -90.33%-129.05%-79.80%-169.94%-67.49%-124.71%-52.47%725.84%276.68%-182.99%-108.34%486.58%-179.55%-320.65%-354.93%-1,068.86%
Operating Margin (Quarter) -77.09%-74.75%-55.98%-145.89%-86.41%-95.16%-57.65%234.68%-277.32%-220.88%-108.61%-96.69%-166.33%-266.47%-347.22%-1,068.86%
Net Margin (Quarter) -77.09%-74.75%-386.92%-476.94%-86.41%-95.98%-51.97%234.46%-282.96%-230.49%-116.13%-103.21%-169.49%-277.03%-326.54%-1,068.86%
Efficiency
Inventory Average (Quarter) 7.95B7.31B2.08B2.08B0.00B0.00B
Assets Average (Quarter) 0.07B0.03B0.03B0.06B0.03B0.02B0.03B0.03B
Equity Average (Quarter) 0.08B0.02B4.52B
Invested Capital (Quarter) 0.08B0.08B0.04B0.02B0.02B9.02B0.02B-0.02B
Asset Utilization Ratio (Quarter) 0.430.800.690.491.172.020.960.83
Leverage & Solvency
Debt to Equity (Quarter) 0.160.27781.921.202.059.93-0.51
Debt Ratio (Quarter) 0.100.12251.040.320.00B0.340.75
Equity Ratio (Quarter) 0.610.460.320.270.00B0.03-1.45
Valuation
Enterprise Value (Quarter) -0.03B-0.03B-19.85B-0.03B-0.01B-0.00B-0.02B-0.01B-0.00B-0.01B-0.00B-0.01B
Return Ratios
Return on Sales (Quarter) -0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.02%-0.03%-0.02%-0.01%-0.01%-0.02%-0.03%-0.03%-0.11%
Return on Capital Employed (Quarter) -13.36%0.08%-178.53%0.12%193.90%389.12%444.36%
Return on Assets (Quarter) 0.00%0.00%0.00%-0.01%-0.02%-0.03%-0.02%-0.04%
Return on Equity (Quarter) 0.00%0.00%